Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Yu

Showing results (1471-1480 of 1,996) with videos related to

Pageof 200
Sort By:
Clinical Pharmacology and Therapeutics|February 12, 2015
Novel bioequivalence approach for narrow therapeutic index drugsL X Yu, W Jiang, X Zhang, et al.
Magnetic Resonance in Medicine|December 7, 2000
High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agentX Yu, S K Song, J Chen, et al.
Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Single-nucleotide polymorphisms in the p53 pathwayS L Harris, G Gil, W Hu, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinomaY Zhang, L F Wang, J H Gao, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces endopolyploidy in Chinese hamster ovary cellsB B Hasinoff, M E Abram, G L Chee, et al.
Blood Cells, Molecules & Diseases|February 8, 2002
Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin alleleC T Noguchi, M Gladwin, B Diwan, et al.
Gut|November 14, 2007
Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytesK Murao, H Imachi, X Yu, et al.
Osteoarthritis and Cartilage|February 25, 2010
Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck diseaseY M Xiong, X Y Mo, X Z Zou, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
Synthesis of the first sulfur-35-labeled hERG radioligandConrad E Raab, John W Butcher, Thomas M Connolly, et al.
The Annals of Pharmacotherapy|September 25, 2009
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug AdministrationBarbara M Davit, Patrick E Nwakama, Gary J Buehler, et al.
Pageof 200

Showing results (1471-1480 of 1,996) with videos related to

Sort By:
Pageof 200
Clinical Pharmacology and Therapeutics|February 12, 2015
Novel bioequivalence approach for narrow therapeutic index drugsL X Yu, W Jiang, X Zhang, et al.
Magnetic Resonance in Medicine|December 7, 2000
High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agentX Yu, S K Song, J Chen, et al.
Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Single-nucleotide polymorphisms in the p53 pathwayS L Harris, G Gil, W Hu, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinomaY Zhang, L F Wang, J H Gao, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 25, 2000
The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces endopolyploidy in Chinese hamster ovary cellsB B Hasinoff, M E Abram, G L Chee, et al.
Blood Cells, Molecules & Diseases|February 8, 2002
Pathophysiology of a sickle cell trait mouse model: human alpha(beta)(S) transgenes with one mouse beta-globin alleleC T Noguchi, M Gladwin, B Diwan, et al.
Gut|November 14, 2007
Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytesK Murao, H Imachi, X Yu, et al.
Osteoarthritis and Cartilage|February 25, 2010
Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck diseaseY M Xiong, X Y Mo, X Z Zou, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
Synthesis of the first sulfur-35-labeled hERG radioligandConrad E Raab, John W Butcher, Thomas M Connolly, et al.
The Annals of Pharmacotherapy|September 25, 2009
Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug AdministrationBarbara M Davit, Patrick E Nwakama, Gary J Buehler, et al.
Pageof 200